메뉴 건너뛰기
Oncologie
Volumn 4, Issue 7, 2002, Pages 419-422
The role of octreotide in palliative care;Place des analogues de la somatostatine en soins palliatifs
Author keywords

Bowel obstruction; Chronic diarrhea; Fistula; Octreotide; Palliative care
Indexed keywords

ANTIEMETIC AGENT; CORTICOSTEROID; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; OCTREOTIDE; OPIATE; SPASMOLYTIC AGENT;
EID: 0036868113     PISSN: 12923818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)
References (8)
  • 1
    • 0030200821 scopus 로고    scopus 로고
    • Palliative treatment of upper intestinal obstruction by gynecological malignacy: The usefulness of percutaneous endoscopic gastrostomy
    • Campagnutta E, Cannizzaro R, et al (1996) Palliative treatment of upper intestinal obstruction by gynecological malignacy: The usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol 62, 103-105
    • (1996) Gynecol Oncol , vol.62 , pp. 103-105
    • Campagnutta, E.1    Cannizzaro, R.2
  • 2
    • 0032955693 scopus 로고    scopus 로고
    • Octreotide in the traitment of refractory diarrhea
    • Fried M (1999) Octreotide in the traitment of refractory diarrhea. Digestion 60 (Suppl 2): 42-46
    • (1999) Digestion , vol.60 , Issue.SUPPL. 2 , pp. 42-46
    • Fried, M.1
  • 3
    • 0029996754 scopus 로고    scopus 로고
    • Octreotide in the management of bowel onstruction in terminal ovarian cancer
    • Mangili G, Franchi M, et al. (1996) Octreotide in the management of bowel onstruction in terminal ovarian cancer. Gynecol Oncol 61: 345-348
    • (1996) Gynecol Oncol , vol.61 , pp. 345-348
    • Mangili, G.1    Franchi, M.2
  • 4
    • 0027445761 scopus 로고
    • Octreotide in relieving gastrointestinal symptoms due to bowel obstruction
    • Mercadante S, Spoldi E, et al. (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7: 295-299
    • (1993) Palliat Med , vol.7 , pp. 295-299
    • Mercadante, S.1    Spoldi, E.2
  • 5
    • 0003113729 scopus 로고
    • Octreotide in terminal maligant obstruction of the gastro intestinal tract
    • Riley J, Fallon MT (1994) Octreotide in terminal maligant obstruction of the gastro intestinal tract. European Journal of Palliative Care 1: 23-28
    • (1994) European Journal of Palliative Care , vol.1 , pp. 23-28
    • Riley, J.1    Fallon, M.T.2
  • 6
    • 0033980027 scopus 로고    scopus 로고
    • Role of octreotide, scopolamine, buthylbromide and hydratation in symptom control of patient with inoperable bowel obstruction and nasogastric tubes: A prospective randomized trial
    • Ripamonti C, Mercadante S, et al. (2000) Role of octreotide, scopolamine, buthylbromide and hydratation in symptom control of patient with inoperable bowel obstruction and nasogastric tubes: A prospective randomized trial. Journal of Pain and Symptom Management 19: 23-34
    • (2000) Journal of Pain and Symptom Management , vol.19 , pp. 23-34
    • Ripamonti, C.1    Mercadante, S.2
  • 7
    • 17844375665 scopus 로고    scopus 로고
    • Clinical practice recommendation for the management of bowel obstruction in patient with end stage cancer
    • Ripamonti C, Twycross R, et al. (2001) Clinical practice recommendation for the management of bowel obstruction in patient with end stage cancer. Support Care Cancer 9: 223-233
    • (2001) Support Care Cancer , vol.9 , pp. 223-233
    • Ripamonti, C.1    Twycross, R.2
  • 8
    • 0035666154 scopus 로고    scopus 로고
    • Systematic review: The use of somatostatin or ocreotide in refractory diarrhea
    • Szilagyi A, Shrier I (2001) Systematic review: The use of somatostatin or ocreotide in refractory diarrhea. Aliment Pharmacol Ther 15: 1889-1897
    • (2001) Aliment Pharmacol Ther , vol.15 , pp. 1889-1897
    • Szilagyi, A.1    Shrier, I.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.